Search

Your search keyword '"Marais, A. David"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Marais, A. David" Remove constraint Author: "Marais, A. David" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
104 results on '"Marais, A. David"'

Search Results

1. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

2. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

6. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

7. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

10. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

11. Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa.

12. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

13. Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

14. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

18. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

20. Homozygous Familial Hypercholesterolemia Treatment: New Developments.

23. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

30. Clinical heterogeneity in monogenic chylomicronaemia.

31. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.

36. Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms.

37. RNA-based therapy in the management of lipid disorders: a review.

45. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.

46. Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease

47. Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.

48. Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.

50. A Pharmacogenetic Approach to the Treatment of Patients With Mutations.

Catalog

Books, media, physical & digital resources